COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Include endpoints

Check conditions None

Apply sex-specific rule None

diagram downward connector PULM_PNEUMONIA_SEPSIS

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 34103 15092 19011
Unadjusted prevalence (%) 13.11 10.27 16.81
Mean age at first event (years) 54.33 51.52 56.57

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.11 7.88 [7.13, 8.71] <1e-100 9169
15 years 0.07 9.63 [8.83, 10.51] <1e-100 8749
5 years 0.03 19.83 [18.29, 21.51] <1e-100 6752
1 year 0.01 52.30 [46.06, 59.38] <1e-100 4234

Correlations

Index endpoint: PULM_PNEUMONIA_SEPSIS – COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia
GWS hits: 2

Survival analyses between endpoints

Plot

before COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia
after COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia